LD-2 disclosure · 3rd Quarter - Amendment
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
via OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Expenses$290Kself-filed spend
Client
- Name
- OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
- Location
- Maryland · United States of America
Registrant
- Firm
- OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
- Description
- Pharmaceutical research and development
- Location
- Rockville, Maryland, United States of America
Lobbying activities
1 issueHealth Issues
S.1945 - Mental Health Reform Act of 2015, S.481 - Improving Regulatory Transparency for New Medical Therapies Act, S.1893 - Mental Health Awareness and Improvement Act of 2015, H.R.2624 - Helping Families in Mental Health Crisis Act of 2015
LobbyistsMOLLY RYAN · JOHN BARDI
TargetedSENATE · HOUSE OF REPRESENTATIVES